Skip to main content
Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
19.30
+0.52 (2.77%)
Mar 9, 2026, 1:50 PM EDT - Market open

Biodesix Revenue

In the year 2025, Biodesix had annual revenue of $88.50M with 24.08% growth. Biodesix had revenue of $28.76M in the quarter ending December 31, 2025, with 40.76% growth.

Revenue (ttm)
$88.50M
Revenue Growth
+24.08%
P/S Ratio
2.09
Revenue / Employee
$264,967
Employees
334
Market Cap
190.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202588.50M17.18M24.08%
Dec 31, 202471.32M22.24M45.30%
Dec 31, 202349.09M10.88M28.46%
Dec 31, 202238.21M-16.29M-29.89%
Dec 31, 202154.51M8.95M19.64%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Myriad Genetics 824.50M
Castle Biosciences 344.23M
Fulgent Genetics 322.67M
MDxHealth 107.88M
FONAR 106.03M
Prenetics Global 92.39M
Burning Rock Biotech 75.75M
Personalis 69.65M
Revenue Rankings

BDSX News

More News